Fresenius headquarters in Bad Homburg near Frankfurt, Germany, February 27, 2018. REUTERS/Ralph Orlowski FRANKFURT, Feb 9 (Reuters) – German healthcare group Fresenius SE (FREG.DE) said on Thursday it was potentially ready to cede control over Fresenius Medical Care (FMC) (FMEG.DE) , after a fall in earnings at the world’s largest dialysis company. Shares in FMC were down 3.4% at 1538 GMT, while Fresenius stock surged 4.3% after it said it was considering de-consolidating the subsidiary, meaning its sales would no longer be fully integrated into its financial reports. Elliott Investment Management took a stake in Fresenius SE in October, a person familiar with the matter told Reuters at the time, sparking speculation the activist investor might push for a break up of the diversified healthcare company. FMC, which has been hit hard by U.S. staff shortages and cost inflation this year, slashed its annual outlook twice last year, also pulling down Fresenius’ forecasts. Confirming an earlier report by business magazine WirtschaftsWoche, Fresenius said in a statement that it was also looking into abandoning FMC’s legal form of AG & Co. KGaA, which gives it strategic control and the right to appoint leadership positions even though it only holds 32% […]
K&X Design and Investment Technology, LLC
Invest The Invisible Impact
K&X Design and Investment Technology, LLC
Invest The Invisible Impact
